Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK, Gilead HIV Fixed-Dose Combination Drugs Clear FDA

Aug 02 2004

• By Catherine Harrison

Related Content

HIV/AIDS NDAs For Fixed-Dose Combination Will Be Exempt From User Fees

May 17 2004

GSK Expects To Launch Once-Daily HIV Combo Product Ahead Of Gilead

Apr 29 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window